National Health Act 1953 - Amendment determination under subsections 85A(1) and (2) and 88(1C) - Prescription of pharmaceutical benefits by authorised optometrists (No. PB 52 of 2009)

Overview

The National Health Act 1953 was enacted to provide the legislative basis for the Pharmaceutical Benefits Scheme (PBS), ensuring that all Australians have reliable, timely, and affordable access to a wide range of medicines. This Act is administered by the Parliament of Australia, with the primary policy objective of making essential medicines accessible and affordable to the public. The Act allows the Minister for Health to declare drugs and medicinal preparations to be listed drugs, which are then subject to the provisions of the PBS. This legislative instrument, F2009L02292, amends determinations under subsections 85A(1) and (2) and 88(1C) of the Act, reflecting recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC) and involving an ongoing consultation process with various stakeholders. The amendments, which came into effect on 1 July 2009, aim to further refine the criteria for pharmaceutical benefits under the PBS, ensuring that the scheme remains effective and responsive to the medical needs and economic considerations of the Australian population.

Scope and Application

The National Health Act 1953 Amendment Determination under subsections 85A(1) and (2) and 88(1C) applies to the Pharmaceutical Benefits Scheme (PBS), a Commonwealth initiative designed to ensure all Australians have reliable, timely, and affordable access to a wide range of medicines. This Act, through its amendments, governs the forms, manner, and quantities of pharmaceutical items that can be prescribed, and it also extends the authority of optometrists to prescribe certain pharmaceutical benefits. The Act applies to pharmaceutical items declared by the Minister, as well as to certain extemporaneously-prepared medicinal preparations. It impacts various entities including pharmaceutical companies, healthcare providers, and consumers by setting out the parameters under which medicines can be prescribed and supplied. The amendments, which reflect recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), are designed to ensure that the PBS remains effective and responsive to the health needs of the Australian population. The Act operates nationally, with the Minister having the authority to make determinations through subordinate instruments. These amendments, which commenced on 1 July 2009, extend the scope of the Act by adding specific pharmaceutical items and modifying existing provisions to better align with the current health landscape.

Key Provisions

The National Health Act 1953, as amended, establishes the Pharmaceutical Benefits Scheme (PBS), which is the mechanism through which the Commonwealth ensures Australians have access to affordable and timely medicines. Key sections relevant to this amendment include subsections 85A(1) and (2), and 88(1C). These subsections empower the Minister to determine the forms of pharmaceutical benefits and items that may be prescribed, as well as various aspects of prescription writing by specified classes of persons. The Minister can set limits on quantities, repeat supplies, and the manner of administration in prescriptions. Additionally, subsection 88(1C) allows the Minister to specify which pharmaceutical benefits an optometrist is authorised to prescribe from a specified date. The Act imposes specific obligations on the parties it governs. The Minister, under the authority granted by the Act, must make determinations regarding the forms of listed drugs, the administration of these drugs, and the branding of pharmaceutical items. Furthermore, the Minister must consult with the Pharmaceutical Benefits Advisory Committee (PBAC) to make informed decisions about which drugs should be included in the PBS and the conditions under which they can be prescribed. The PBAC, composed of experts from various healthcare fields, provides recommendations based on medical effectiveness, safety, and cost-effectiveness. Failure to comply with the provisions of the Act may result in civil or criminal penalties. While the specific penalties are not detailed in the provided text, breaches of pharmaceutical regulations generally carry significant fines and potential imprisonment. The precise consequences would depend on the nature and severity of the breach, and the courts would take these factors into account when determining penalties. In summary, the National Health Act 1953, as amended, outlines the legislative framework for the PBS, with key provisions in subsections 85A(1) and (2), and 88(1C). These provisions allow the Minister to make determinations about pharmaceutical benefits and prescription conditions, guided by recommendations from the PBAC. Compliance with these provisions is essential, and breaches may lead to civil or criminal penalties, although the exact penalties are not detailed in the provided text.